Welsh Health Specialised Services Committee

What Welsh Health Specialised Services Committee does

The NHS Wales Joint Commissioning Committee (NWJCC), which succeeded the Welsh Health Specialised Services Committee (WHSSC) in 2021, is a statutory joint committee of the seven Welsh Local Health Boards. It is hosted by Cwm Taf Morgannwg University Health Board, headquartered in Pontypridd with additional offices in Mold and Nantgarw/Treforest, and employs approximately 120 staff. Its mandate is the planning, commissioning, and performance oversight of highly specialised healthcare services for the population of Wales, encompassing around 220 commissioned service lines.

The organisation manages an annual commissioning budget of approximately £1.14 billion, allocated across specialised services including mental health, cancer treatment, cardiac services, renal care, and rare conditions. It deploys a portfolio of operational systems and policy frameworks including the Blueteq High Cost Drugs commissioning system, the Welsh Ambulance Service Indicators Dashboard, the NHS 111 Wales Press 2 Mental Health Dashboard, Individual Patient Funding Request (IPFR) processes, the Welsh Kidney Network, and clinical policy portfolios for specialised services. It also publishes performance frameworks such as the SAFER patient flow guidance.

Funding derives entirely from public sector allocations channelled through the seven constituent Welsh Health Boards, with no commercial revenue. The organisation works in partnership with NHS England on cross-border specialised services, the All Wales Therapeutics and Toxicology Centre (AWTTC), Digital Health and Care Wales (DHCW), the Wales Air Ambulance Charitable Trust, and the patient advocacy body Llais. Its customer base is structurally captive — the seven Health Boards are simultaneously the commissioning constituencies and the service recipients — making customer concentration a defining structural feature rather than a commercial risk.

Name

Welsh Health Specialised Services Committee

Legal name

NHS Wales Joint Commissioning Committee

Website

https://whssc.nhs.wales

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

11–50 employees

Short description

The NHS Wales Joint Commissioning Committee (formerly WHSSC) is a statutory joint committee of seven Welsh Health Boards that plans and commissions approximately 220 specialised healthcare services across Wales on a £1.14 billion annual budget, employing roughly 120 staff.

Ownership category

akta.pro rank

Product category

Healthcare Commissioning Services

SIC

Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Public Health Policy, Planning & Governance (BPAIAJAB)

akta.pro secondary industry

Managed Care Entity Administration for Medicaid (MCO/PHP/PIHP/PAHP) (HLAEAEAJ)

Keywords

• Specialised health commissioning
• NHS Wales services
• High-cost drugs management
• Health board commissioning
• Specialised clinical services

Headquarters

HQ city

Nantgarw

HQ country

United Kingdom

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Others

Revenue model

1. NHS Commissioned Services: NWJCC operates a £1.14bn budget to commission around 220 services including NHS 111, ambulance services, specialised rare disease services, and mental health services on behalf of the seven Welsh health boards.
2. Hosting Arrangement: NWJCC is hosted by Cwm Taf Morgannwg University Health Board, with all recruitment managed through their services.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

NHS Wales Joint Commissioning Committee (NWJCC), formerly the Welsh Health Specialised Services Committee (WHSSC), is a statutory joint committee of the seven Welsh health boards that plans, commissions and oversees approximately 220 specialised health services across Wales, operating a £1.14 billion budget. Its portfolio spans NHS 111, ambulance services, rare disease treatments, mental health, cancer, cardiac, children's, neurosciences, trauma and critical care, fertility, genomics, plastic surgery and burns, and the Welsh Kidney Network. It also operates supporting digital and policy products including the Blueteq High Cost Drugs System, the Ambulance Service Indicators Dashboard, the NHS 111 Wales Press 2 Mental Health Support Dashboard, Individual Patient Funding Requests (IPFR) and a portfolio of Clinical Commissioning Policies.

Product overview

The NHS Wales Joint Commissioning Committee (NWJCC), formerly the Welsh Health Specialised Services Committee (WHSSC), is a joint committee of seven Welsh health boards that commissions specialised health services across Wales. The organisation operates a portfolio of approximately 220 services including NHS 111 and ambulance services, mental health services, and specialised rare disease services, with a budget of £1.14 billion. Key digital products include the Blueteq High Cost Drugs System for medicines governance, the Ambulance Service Indicators Dashboard for performance monitoring, the NHS 111 Wales Press 2 Mental Health Support Dashboard, and a comprehensive portfolio of Clinical Policies covering 14 service categories. The organisation also manages Individual Patient Funding Requests (IPFR) for treatments not routinely commissioned.

Differentiator

Problem solved

Functional benefit

Products and services

• NHS Wales Joint Commissioning Committee Commissioning Service Statutory joint commissioning service responsible for planning, commissioning and overseeing approximately 220 specialised health services across Wales on behalf of the seven Welsh health boards, including NHS 111, ambulance services, rare disease services, mental health, cancer, cardiac and paediatric care, with a £1.14bn budget.
• Blueteq High Cost Drugs System Web-based software system used across NHS Wales to manage and authorise High-Cost Drugs across a wide range of healthcare conditions, recording patient demographics, clinical characteristics, treatment histories, treatment response and safety data, and ensuring compliance with AWMSG and NICE Health Technology Appraisal guidance.
• Ambulance Service Indicators Dashboard Interactive dashboard providing monthly updates on ambulance service performance in Wales, explaining the 5-Step Ambulance Model and allowing users to view data by Wales-wide or Health Board level with dataset export capabilities, backed by StatsWales integration.
• NHS 111 Wales Press 2: Mental Health Support Service and Dashboard 24/7 mental health crisis helpline accessible by dialling NHS 111 and pressing option 2, with an associated dashboard providing demographic summaries, time/date analysis and health board/local authority statistics on mental health calls documented via the Adastra clinical system.
• Clinical Policies Portfolio Comprehensive portfolio of commissioning policies and service specifications covering specialised services including Cancer and Blood, Cardiac and Thoracic, Children Services, Fertility, Gender, Genomics, Mental Health, Neurosciences, Plastic Surgery and Burns, Posture and Mobility, Rare Diseases, Trauma and Critical Care, and Welsh Kidney Network.
• Individual Patient Funding Requests (IPFR) Service Process for patients and clinicians to request funding for treatments not routinely commissioned by NWJCC, providing a managed route to exceptional funding decisions through commissioning policy and IPFR decision pathways.
• Welsh Kidney Network Specialised kidney services including dialysis away from base, home therapies, vascular access services, living donor expenses and holiday dialysis treatment funding for Welsh renal patients.
• SAFER Guidance Good practice guide promoting safe and timely discharge, improving patient flow and preventing unnecessary waiting through combined rules for adult inpatient wards, published as a practical NHS Wales guidance product.

Named customers3 records

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

Feature1 record

Partnerships

Six partnerships are on record, tiered core and minor.

• Cwm Taf Morgannwg University Health BoardcoreStrategic or Co-development PartnerHost organisation for NWJCC. All recruitment is managed through their services. Provides corporate support functions including HR, finance, and governance.
• All Wales Therapeutics and Toxicology Centre (AWTTC)coreStrategic or Co-development PartnerSupports AWMSG and its subgroups. Leads the roll-out of Blueteq High Cost Drugs system for secondary and primary care from April 2023.
• NHS EnglandcoreStrategic or Co-development PartnerCollaborates with NHS England on cross-border treatments through Blueteq system. Joint commissioning of services including Gender Identity Services. Ensures seamless treatment attribution across England and Wales.
• Llais (Your voice in health and social care)minorStrategic or Co-development PartnerIndependent body that provides information, advice and support to members of the public who may wish to raise a concern about NHS services. Helps complainants navigate the concerns process.
• Wales Air Ambulance CharitycoreStrategic or Co-development PartnerPartnership with EMRTS (Emergency Medical Retrieval and Transfer Service) to provide air ambulance service for Wales. EMRTS works with the charity to deliver the service.
• Seven Welsh Health BoardscoreChannel Partner/ Reseller/ DistributorNWJCC is a joint committee of the seven health boards in Wales. The health boards are both the commissioners (via NWJCC) and recipients of commissioned specialised services.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Healthcare Improvement Scotland: Statutory body in Scotland focused on evidence-based clinical improvement, standards, and quality across NHS Scotland. Broadly comparable as a UK NHS public-sector health governance and standard-setting body operating alongside specialised commissioners.
• NHS Business Services Authority (NHSBSA): Arm's length body of the UK Department of Health that provides central back-office services (prescription processing, payments, data) to NHS organisations. Comparable to NWJCC in operating as a national NHS administrative/commissioning-support entity with public-sector data scale.
• Public Health Wales NHS Trust: The national public health agency for Wales, providing health protection, screening, microbiology, and health intelligence services. Adjacent to NWJCC in the Welsh NHS architecture and overlapping in immunisation, screening, and population health policy domains.

Direct peers

• NHS Scotland — National Services Scotland (NSS): Scotland's national health board that commissions and delivers specialised services on behalf of NHS Scotland territorial boards. Mirrors NWJCC's function of joint commissioning across multiple health boards, with shared exposure to high-cost drugs and rare disease pathways.
• Health and Social Care Board (Northern Ireland): Northern Ireland's equivalent commissioning body for specialised and regional health services, performing a joint planning and commissioning function across HSC trusts in a similar way to NWJCC across Welsh health boards.
• NHS England Specialised Commissioning: The national NHS commissioning function for specialised services in England. Most directly comparable to NWJCC in terms of statutory commissioning role, specialised services portfolio, and use of high-cost drug management frameworks — simply at a larger population scale.
• All Wales Therapeutics and Toxicology Centre (AWTTC): AWTTC supports AWMSG and leads the Blueteq high-cost drugs rollout across NHS Wales. Operates as a peer-level, NHS-Wales-wide clinical advisory and medicines governance body with overlapping scope to NWJCC.
• NHS Wales Shared Services Partnership (NWSSP): Shared services arm of NHS Wales providing corporate, procurement, and legal services to all Welsh health boards. Highly comparable as a UK-wide health-system-wide collaborative commissioning arrangement operating at the same Welsh national level.

Emerging players

• Blueteq (software provider): Vendor of the Blueteq High Cost Drugs system used by NWJCC and other UK NHS commissioners. Comparable as a technology layer underpinning specialised commissioning decisions, though it operates as a software supplier rather than a commissioner.

Others

• Cwm Taf Morgannwg University Health Board: Host organisation for NWJCC, providing HR, finance, and governance services. Not a direct commissioning peer but is the structural backbone without which NWJCC could not operate.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/welsh-health-specialised-services-committee

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Welsh Health Specialised Services Committee